Skip to main content

Animations

MJFF Publications

3701 - 3710 of 8571 Results
Title
Year
  • Year
  • 2020
  • 2014
  • 2018
  • 2024
  • 2018
  • 2017
  • 2022
  • 2017
  • 2019
  • 2016
  • Summary Details
    OPEN
    Title: LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived Neurons
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2020.00442
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Safety Study of Transcranial Static Magnetic Field Stimulation (tSMS) of the Human Cortex
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2014.12.002
    Best OA location URL: http://oa.upm.es/41093/
    Citation Count: 50
  • Summary Details
    OPEN
    Title: PP1 Phosphatase Complexes: Undruggable No Longer
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa, elsevier-specific: oa user license
    DOI - Digital Object Identifier: 10.1016/j.cell.2018.08.007
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Investigation of the genetic aetiology of Lewy body diseases with and without dementia
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae190
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/jnc.14569
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-017-0935-1
    Citation Count: 82
  • Summary Details
    OPEN
    Title: BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.1053591
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.489
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Using global team science to identify genetic parkinson's disease worldwide
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25514
    Citation Count: 33
  • Summary Details
    OPEN
    Title: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2016.00174
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.